| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $276.2M | +0.0% |
| Cost of Revenue | $215.6M | +35.6% |
| Gross Profit | $140.1M | +19.5% |
| R&D Expense | $6.4M | -13.8% |
| SG&A Expense | $93.1M | +1.8% |
| Operating Income | $38.4M | +393.8% |
| Interest Expense | $5.8M | -43.3% |
| Pre-tax Income | $28.4M | +4513.8% |
| Income Tax | $8.3M |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.4M | +3.3% |
| Accounts Receivable | $95.3M | +27.9% |
| Inventory | $71.7M | +12.3% |
| Current Assets | $244.4M | +18.2% |
| Total Assets | $636.7M | +3.0% |
| Current Liabilities | $81.0M | +54.5% |
| Long-term Debt | $129.0M | -13.1% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $28.8M | -5.1% |
| Capital Expenditures | $5.2M | -35.8% |
| Investing Cash Flow | -$4.5M | +42.1% |
| Financing Cash Flow | -$22.7M | +19.7% |
| Free Cash Flow | $23.5M | +6.2% |
| +679.5% |
| Net Income | $877K | +0.0% |
| EPS (Basic) | $0.60 | +1400.0% |
| EPS (Diluted) | $0.60 | +1900.0% |
| Total Liabilities |
| $237.5M |
| -0.5% |
| Stockholders' Equity | $399.2M | +5.4% |